Showing 1861-1870 of 3286 results for "".
Are We All Clear?
https://practicaldermatology.com/topics/psoriasis/are-we-all-clear/20725/Understanding the safety of biologics for psoriasis in real-world settings.Emerging Therapies in the Evolving Biologic Platform for Psoriasis Treatment
https://practicaldermatology.com/topics/practice-management/emerging-therapies-in-the-evolving-biologic-platform-for-psoriasis-treatment/21377/Lead Psoriasis Patients Along the Path to Clearance
https://practicaldermatology.com/topics/psoriasis/PD0209_01-php/22873/With so many effective therapies now available, dermatologists must be prepared to guide their patients to the right treatment for their specific presentation.Update on the Treatment of Actinic Keratoses
https://practicaldermatology.com/topics/general-topics/update-on-the-treatment-of-actinic-keratoses/21630/From mainstay therapies to newly approved agents, treatment options for actinic keratoses are growing.Food for Thought: A Closer Look at Diet and Acne
https://practicaldermatology.com/topics/general-topics/food-for-thought-a-closer-look-at-diet-and-acne/21308/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20730/Prescriber, Beware: Understanding and Protecting Drug Compounding
https://practicaldermatology.com/topics/practice-management/prescriber-beware-understanding-and-protecting-drug-compounding/20582/Compounding has been an integral part of the specialty, but changing regulations and new players may converge to bring change.Cosmetics Challenge
https://practicaldermatology.com/topics/general-topics/cosmetics-challenge/21793/Pregnancy and Melanoma: What We Know About the Risks
https://practicaldermatology.com/topics/practice-management/pregnancy-and-melanoma-what-we-know-about-the-risks/21041/Against a backdrop of conflicting findings, a new study suggests a significant risk associated with melanoma during pregnancy.Dupilumab For the Management of Pembrolizumab-induced Rash: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/dupilumab-for-the-management-of-pembrolizumab-induced-rash-a-case-report/23841/